Jason Gerberry
Stock Analyst at Bank of America Securities
(4.89)
# 286
Out of 4,509 analysts
882
Total ratings
59.7%
Success rate
20.4%
Average return
Main Sectors:
Stocks Rated by Jason Gerberry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SUPN Supernus Pharmaceuticals | Maintained: Buy | $63 | $48.46 | +30.00% | 1 | Jul 13, 2026 | |
| ALKS Alkermes | Maintained: Sell | $38 | $51.94 | -26.84% | 41 | Jul 10, 2026 | |
| BMY Bristol-Myers Squibb Company | Reiterated: Buy | $67 → $66 | $57.58 | +14.62% | 13 | Jul 10, 2026 | |
| LLY Eli Lilly and Company | Rated: Buy | $1,251 → $1,334 | $1,188.58 | +12.23% | 16 | Jul 10, 2026 | |
| JAZZ Jazz Pharmaceuticals | Maintained: Buy | n/a | $243.82 | - | 71 | Jul 10, 2026 | |
| JNJ Johnson & Johnson | Reiterated: Hold | $254 → $263 | $256.98 | +2.34% | 11 | Jul 10, 2026 | |
| MRK Merck & Co. | Rated: Buy | $141 | $123.54 | +14.13% | 16 | Jul 10, 2026 | |
| VTRS Viatris | Reiterated: Sell | $10 → $14 | $16.27 | -13.95% | 41 | Jul 10, 2026 | |
| PFE Pfizer | Rated: Hold | $26 | $24.17 | +7.57% | 12 | Jul 10, 2026 | |
| TEVA Teva Pharmaceutical Industries | Reiterated: Buy | $40 | $32.95 | +21.40% | 82 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $626 → $613 | $547.06 | +12.05% | 20 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $233.80 | - | 29 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $56.43 | - | 8 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $111 → $90 | $58.25 | +54.51% | 46 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $89 | $58.14 | +53.08% | 21 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $25 → $20 | $18.72 | +6.84% | 16 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $79 | $77.93 | +1.37% | 19 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $41 | $56.50 | -27.43% | 35 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $234 | $248.08 | -5.68% | 13 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $44 → $35 | $13.63 | +156.79% | 18 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $59.12 | +35.32% | 14 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $43 | $39.71 | +8.29% | 18 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $0.7927 | +152.30% | 14 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 → $31 | $5.59 | +454.56% | 12 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $58.21 | - | 30 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $28.38 | - | 2 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $81 → $93 | $76.40 | +21.73% | 20 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $77 | $68.92 | +11.72% | 14 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $17.77 | +6.92% | 2 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $32 → $28 | $36.84 | -24.00% | 15 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $7.08 | $6.77 | +4.60% | 20 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $13.52 | - | 15 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $1 | $1.76 | -43.18% | 11 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $31.47 | +11.22% | 14 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $15.55 | -35.69% | 13 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $26.42 | - | 1 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $25 → $28 | $30.27 | -7.50% | 18 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $20.01 | -25.02% | 18 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.54 | n/a | 7 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.00 | n/a | 6 | Sep 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $4 → $3.5 | $3.28 | n/a | 7 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $4 → $2 | $7.61 | n/a | 10 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $5 → $1 | $1.44 | n/a | 4 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $10.55 | n/a | 1 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $26 → $10 | $6.26 | n/a | 2 | Jul 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $0.6376 | n/a | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $110 | $298.76 | n/a | 1 | Nov 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $6 | $0.0001 | n/a | 3 | Aug 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $138.50 | n/a | 2 | Jun 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $9 | $2.10 | n/a | 1 | Oct 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $18 | $5.28 | n/a | 7 | Nov 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $0.4144 | n/a | 13 | Nov 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $59 → $37 | $25.48 | n/a | 7 | Nov 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $110 → $81 | $10.22 | n/a | 9 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $33 → $24 | $17.01 | n/a | 7 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $49.48 | n/a | 1 | Aug 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $14 | $4.47 | n/a | 9 | Aug 5, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 | $177.11 | n/a | 1 | Jul 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0055 | n/a | 3 | Jan 19, 2016 |
Supernus Pharmaceuticals
Jul 13, 2026
Maintained: Buy
Price Target: $63
Current: $48.46
Upside: +30.00%
Alkermes
Jul 10, 2026
Maintained: Sell
Price Target: $38
Current: $51.94
Upside: -26.84%
Bristol-Myers Squibb Company
Jul 10, 2026
Reiterated: Buy
Price Target: $67 → $66
Current: $57.58
Upside: +14.62%
Eli Lilly and Company
Jul 10, 2026
Rated: Buy
Price Target: $1,251 → $1,334
Current: $1,188.58
Upside: +12.23%
Jazz Pharmaceuticals
Jul 10, 2026
Maintained: Buy
Price Target: n/a
Current: $243.82
Upside: -
Johnson & Johnson
Jul 10, 2026
Reiterated: Hold
Price Target: $254 → $263
Current: $256.98
Upside: +2.34%
Merck & Co.
Jul 10, 2026
Rated: Buy
Price Target: $141
Current: $123.54
Upside: +14.13%
Viatris
Jul 10, 2026
Reiterated: Sell
Price Target: $10 → $14
Current: $16.27
Upside: -13.95%
Pfizer
Jul 10, 2026
Rated: Hold
Price Target: $26
Current: $24.17
Upside: +7.57%
Teva Pharmaceutical Industries
Jul 10, 2026
Reiterated: Buy
Price Target: $40
Current: $32.95
Upside: +21.40%
Jul 10, 2026
Reiterated: Hold
Price Target: $626 → $613
Current: $547.06
Upside: +12.05%
Jul 10, 2026
Maintained: Buy
Price Target: n/a
Current: $233.80
Upside: -
Jul 10, 2026
Maintained: Buy
Price Target: n/a
Current: $56.43
Upside: -
Jul 9, 2026
Reiterated: Buy
Price Target: $111 → $90
Current: $58.25
Upside: +54.51%
Jul 8, 2026
Maintained: Buy
Price Target: $89
Current: $58.14
Upside: +53.08%
Jun 29, 2026
Downgraded: Sell
Price Target: $25 → $20
Current: $18.72
Upside: +6.84%
Jun 29, 2026
Downgraded: Hold
Price Target: $79
Current: $77.93
Upside: +1.37%
Jun 22, 2026
Maintained: Sell
Price Target: $41
Current: $56.50
Upside: -27.43%
Jun 22, 2026
Maintained: Buy
Price Target: $234
Current: $248.08
Upside: -5.68%
Jun 1, 2026
Maintained: Buy
Price Target: $44 → $35
Current: $13.63
Upside: +156.79%
May 29, 2026
Reiterated: Buy
Price Target: $80
Current: $59.12
Upside: +35.32%
May 21, 2026
Maintained: Buy
Price Target: $32 → $43
Current: $39.71
Upside: +8.29%
May 14, 2026
Reiterated: Buy
Price Target: $2
Current: $0.7927
Upside: +152.30%
May 12, 2026
Maintained: Buy
Price Target: $29 → $31
Current: $5.59
Upside: +454.56%
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $58.21
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $28.38
Upside: -
Apr 20, 2026
Maintained: Buy
Price Target: $81 → $93
Current: $76.40
Upside: +21.73%
Mar 9, 2026
Reiterated: Buy
Price Target: $50 → $77
Current: $68.92
Upside: +11.72%
Mar 3, 2026
Reiterated: Buy
Price Target: $19
Current: $17.77
Upside: +6.92%
Feb 24, 2026
Reiterated: Sell
Price Target: $32 → $28
Current: $36.84
Upside: -24.00%
Feb 18, 2026
Reiterated: Sell
Price Target: $7.08
Current: $6.77
Upside: +4.60%
Feb 13, 2026
Maintained: Sell
Price Target: n/a
Current: $13.52
Upside: -
Jan 12, 2026
Maintained: Sell
Price Target: $1
Current: $1.76
Upside: -43.18%
Dec 8, 2025
Maintained: Buy
Price Target: $35
Current: $31.47
Upside: +11.22%
Nov 10, 2025
Reiterated: Hold
Price Target: $10
Current: $15.55
Upside: -35.69%
Nov 7, 2025
Maintained: Sell
Price Target: n/a
Current: $26.42
Upside: -
Nov 6, 2025
Reiterated: Sell
Price Target: $25 → $28
Current: $30.27
Upside: -7.50%
Nov 6, 2025
Reiterated: Buy
Price Target: $15
Current: $20.01
Upside: -25.02%
Oct 30, 2023
Rated: Hold
Price Target: n/a
Current: $1.54
Upside: n/a
Sep 28, 2023
Rated: Hold
Price Target: n/a
Current: $2.00
Upside: n/a
Aug 9, 2023
Maintained: Sell
Price Target: $4 → $3.5
Current: $3.28
Upside: n/a
Aug 8, 2023
Downgraded: Sell
Price Target: $4 → $2
Current: $7.61
Upside: n/a
Jan 5, 2023
Maintained: Sell
Price Target: $5 → $1
Current: $1.44
Upside: n/a
May 17, 2022
Maintained: Buy
Price Target: $11
Current: $10.55
Upside: n/a
Jul 15, 2020
Downgraded: Hold
Price Target: $26 → $10
Current: $6.26
Upside: n/a
Mar 11, 2020
Initiated Coverage: Buy
Price Target: $32
Current: $0.6376
Upside: n/a
Nov 13, 2019
Initiated Coverage: Buy
Price Target: $110
Current: $298.76
Upside: n/a
Aug 20, 2019
Maintained: Buy
Price Target: $5 → $6
Current: $0.0001
Upside: n/a
Jun 28, 2019
Downgraded: Sell
Price Target: n/a
Current: $138.50
Upside: n/a
Oct 16, 2018
Downgraded: Sell
Price Target: $9
Current: $2.10
Upside: n/a
Nov 20, 2016
Reiterated: Buy
Price Target: $14 → $18
Current: $5.28
Upside: n/a
Nov 15, 2016
Reiterated: Buy
Price Target: $34
Current: $0.4144
Upside: n/a
Nov 2, 2016
Reiterated: Hold
Price Target: $59 → $37
Current: $25.48
Upside: n/a
Aug 10, 2016
Reiterated: Hold
Price Target: $110 → $81
Current: $10.22
Upside: n/a
Aug 9, 2016
Reiterated: Hold
Price Target: $33 → $24
Current: $17.01
Upside: n/a
Aug 8, 2016
Maintained: Hold
Price Target: n/a
Current: $49.48
Upside: n/a
Aug 5, 2016
Reiterated: Hold
Price Target: $10 → $14
Current: $4.47
Upside: n/a
Jul 13, 2016
Maintained: Buy
Price Target: $70
Current: $177.11
Upside: n/a
Jan 19, 2016
Downgraded: Hold
Price Target: n/a
Current: $0.0055
Upside: n/a